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Background. Suicide is a leading cause of death and has been strongly associated with aﬀective disorders. The
inﬂuence of aﬀective disorder polarity on subsequent suicide attempts or completions and any diﬀerential eﬀect of
suicide risk factors by polarity were assessed in a prospective cohort.
Method. Participants with major aﬀective disorders in the National Institute of Mental Health (NIMH) Collaborative
Depression Study (CDS) were followed prospectively for up to 25 years. A total of 909 participants meeting
prospective diagnostic criteria for major depressive and bipolar disorders were followed through 4204 mood cycles.
Suicidal behavior was deﬁned as suicide attempts or completions. Mixed-eﬀects, grouped-time survival analysis
assessed risk of suicidal behavior and diﬀerential eﬀects of risk factors for suicidal behavior by polarity. In addition
to polarity, the main eﬀects of age, gender, hopelessness, married status, prior suicide attempts and active substance
abuse were modeled, with mood cycle as the unit of analysis.
Results. After controlling for age of onset, there were no diﬀerences in prior suicide attempts by polarity although
bipolar participants had more prior severe attempts. During follow-up, 40 cycles ended in suicide and 384 cycles
contained at least one suicide attempt. Age, hopelessness and active substance abuse but not polarity predicted
suicidal behavior. The eﬀects of risk factors did not diﬀer by polarity.
Conclusions. Bipolarity does not independently inﬂuence risk of suicidal behavior or alter the inﬂuence of well-
established suicide risk factors within aﬀective disorders. Suicide risk assessment strategies may continue to appraise
these common risk factors without regard to mood polarity.
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Introduction
Unipolar and bipolar disorders diﬀer with regard to
several clinical and course of illness variables (Serretti
et al. 2002). The validity of the bipolar versus unipolar
distinction for aﬀective disorders is supported by
a general diagnostic stability (Rice et al. 1986, 1992 ;
Coryell et al. 1989), familial aggregation (Coryell et al.
1984 ; Endicott et al. 1985 ; Rice et al. 1987) and course
of illness (Coryell et al. 1989 ; Goldberg & Harrow,
2004). One important sequela of aﬀective disorders is
suicide. Suicide was the ﬁfth leading cause of death
when ranked by years of potential life lost before age
65 in the USA from 1999 to 2002 (CDC, 2005), and the
majority of suicide victims have a unipolar or bipolar
depressive disorder at the time of suicide (Rihmer,
1996 ; Mann et al. 2005).
Several (Dunner et al. 1976; Kupfer et al. 1988 ;
Tondo et al. 1999) but not all (Cassano et al. 1992)
retrospective studies have suggested higher rates of
suicide attempts among individuals with bipolar,
particularly type II, versus unipolar disorders. Bipolar
disorder was associated with greater risk of suicide
attempts and completions in one prospective study
of 2826 Italian out-patients with aﬀective disorders
followed for a mean of 3.6 years, during which 27
completed suicides and 363 suicide attempts were re-
corded (Tondo et al. 2007). However, bipolar disorder
has not been consistently associated with greater risk
of suicidality prospectively (Coryell et al. 1987). For
bipolar patients, suicide attempts are most likely to
occur in the setting of depressed states (Tondo et al.
1999 ; Oquendo et al. 2000 ; Valtonen et al. 2005),
although mixed states and cycling have also been
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associated (Tondo et al. 1999 ; Dalton et al. 2003 ;
Valtonen et al. 2005). To our knowledge, there are
no studies that directly test for diﬀerential eﬀects of
well-established risk factors for suicide by aﬀective
disorder polarity.
The National Institute of Mental Health (NIMH)
Collaborative Depression Study (CDS) dataset pro-
vides a unique opportunity to assess diﬀerential
eﬀects of risk factors for suicide on account of its
duration, size and scope. To enhance the accuracy of
diagnosis and reduce the risk of misclassiﬁcation
from relying solely on cross-sectional diagnoses, we
examined the risk of suicide outcomes based on a
prospective rather than an initial diagnosis. To make
use of our long-term prospective dataset eﬀectively,
we further analyzed risk factors at the beginning of a
mood cycle rather than simply at study intake. Given
disparate ﬁndings in previous studies regarding risk
of suicide outcomes by subtype of aﬀective disorder,
we sought to explore potential diﬀerential eﬀects of
previously identiﬁed risk factors by aﬀective disorder
polarity. With limited background research on this
topic, we hypothesized that risk factors for suicide
would not diﬀer signiﬁcantly by polarity. Although
several analyses of the entire CDS dataset have
assessed suicide risk factors (Scheftner et al. 1988 ;
Fawcett et al. 1990 ; Young et al. 1994 ; Coryell et al.
2001, 2002 ; Maser et al. 2002), only one has looked at
aﬀective disorder type as a risk factor for suicide
(Fawcett et al. 1987). The Fawcett et al. (1987) study
compared 25 patients who committed suicide by
4-year follow-up with those who did not, over a var-
iety of clinical variables. Diagnostic subcategories did
not diﬀerentiate completers from non-completers as
assessed by Fisher’s exact test. No CDS analysis has
used prospective diagnoses in the study of suicide risk
or compared the diﬀerential eﬀects (interaction) of risk
factors by aﬀective disorder polarity.
Method
Study design
Patients with aﬀective disorders were recruited for
participation in the NIMH Collaborative Program on
the Psychobiology of Depression from ﬁve academic
centers : Massachusetts General Hospital and Harvard
University in Boston, Rush Presbyterian – St Luke’s
Medical Center in Chicago, the University of Iowa
in Iowa City, New York State Psychiatric Institute
and Columbia University in New York, and Wash-
ington University School of Medicine in St Louis.
Participants were Caucasian, English-speaking, and
knowledgeable regarding their biological parents.
Participants further met Research Diagnostic Criteria
(RDC; Spitzer et al. 1978) for major depressive dis-
order, schizo-aﬀective disorder, or manic disorder.
Intake diagnosis was used to identify 936 probands.
This sample was further restricted to 909 participants
with at least one follow-up assessment. Participants
in this sample were followed for a mean of 15.4
(median=19, S.D.=8.8) years and for up to 25 years.
Seventy-eight per cent of participants were followed
for a decade or more.
Follow-up assessments were completed using vari-
ous forms of the Longitudinal Interval Follow-up
Evaluation (LIFE; Keller et al. 1987), which categorizes
severity of psychopathology and was administered
semi-annually in the ﬁrst 5 years and annually there-
after. The LIFE tracked each RDC syndrome weekly
and was used to prospectively diagnose participants
into one of two groups : unipolar and bipolar. An in-
itial diagnosis of bipolar disorder was based on an
intake RDC diagnosis of bipolar II, bipolar I, schizo-
aﬀective manic, or schizo-aﬀective depressed with a
history of mania or schizo-aﬀective mania, mainly af-
fective. The latter category was included as it is almost
identical to mania as deﬁned by the DSM-IV. An initial
diagnosis of unipolar depression was based on intake
RDC diagnosis of major depressive disorder or schizo-
aﬀective disorder, depressed, mainly aﬀective. The
latter category was included as it is analogous to major
depression as deﬁned by the DSM-IV. Follow-up
ratings from the LIFE Psychiatric Status Rating (PSR)
were used to reclassify participants diagnostically.
Participants with unipolar depression on intake, who
developed mania or hypomania during follow-up,
were thus classiﬁed as having bipolar disorder. For
consistency and to make use of the most accurate
diagnoses, prospective diagnoses were used for all
subsequent analyses.
Data analytic procedures
Baseline demographics and prior suicide attempts
were compared between participants with unipolar
and bipolar disorders. Age of onset was estimated
using the earliest of age of ﬁrst psychiatric treatment,
onset of depressive symptoms, or onset of manic
symptoms from the Schedule of Aﬀective Disorders
(SADS; Endicott & Spitzer, 1978, 1979). A retrospec-
tive analysis of suicide attempts was performed to
explore diﬀerences in baseline suicidality prior to en-
rollment in this prospective cohort study. Separate
analyses were conducted for suicide attempts and
severe suicide attempts. Severity of attempt was de-
termined from the SADS using previously used cut-
oﬀs, wherein a severe attempt was operationally
deﬁned as a SADS suicidal intent (item 249) or medical
lethality (item 250) score o4 (Fiedorowicz & Coryell,
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2007). These cut-oﬀs require a ‘serious’ level of suici-
dal intent to kill oneself or at least ‘moderate ’ medical
lethality (i.e. ‘had brief unconsciousness ’). Logistic
regression was performed to control for age of onset in
assessing suicide attempts prior to intake by polarity.
Descriptive statistics related to suicidal behaviors
during follow-up and burden of depressive symptoms
were compiled for those with prospective diagnoses of
unipolar or bipolar disorder. Burden of depressive
symptoms during prospective follow-up was obtained
from the LIFE PSR scales, which were anchored to di-
agnostic thresholds for RDC disorders. Based on pre-
viously published criteria (Judd et al. 2002), a week of
depressive symptoms was operationalized as a PSR
cut-oﬀ score of o3/6 (moderate symptoms or im-
pairment) on the major depression or schizo-aﬀective
depression scale or a score of 3/3 (deﬁnite criteria) for
minor or intermittent depression with a PSR off2 on
the major depressive scale. Diﬀerences in percentage
of time depressed were assessed non-parametrically
using the Wilcoxon rank sum test.
Any suicidal act was included in the survival
analysis, regardless of intent or lethality and including
those acts with minimal, if any, intent or no actual
threat to life. Suicidal behaviors were broadly deﬁned
and encompassed suicide attempts or suicide com-
pletions. Time to suicide attempt or completion by
prospective diagnosis was illustrated using Kaplan–
Meier methods. Survival time represented the number
of weeks from intake into the cohort study until the
outcome of interest : suicide attempt or suicide com-
pletion. Cases lost to follow-up prior to suicide at-
tempts or completions were censored. This analysis
assumed that censoring and suicide attempts or com-
pletions were independent. Death indices from vital
statistics were searched methodically, minimizing
the risk that suicide completions went unrecognized
in censored cases. When the cause of death was un-
known, the death was not included as a suicide in our
analysis. The above analyses were completed using
SAS version 9.1 (SAS Institute Inc., Cary, NC, USA)
and SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
The strength of the association between each of
several previously established and a priori selected
risk factors for completed suicide were examined
in a grouped-time mixed-eﬀects survival analysis
(Hedeker et al. 2000). Given that risk factors may
change over time, the unit of analysis was changed
from individual participant to mood cycle to make
best use of the prospective data. The mood cycle in-
cluded a mood episode and the subsequent period of
recovery until next episode, if applicable. Cycle length
was grouped as a grouped-time, ordinal variable into
the following 10 categories : f8 weeks (f2 months),
9–16 weeks (2–4 months), 17–26 weeks (4–6 months),
27–36 weeks (6–9 months), 37–52 weeks (9–12
months), 53–104 weeks (1–2 years), 105–156 weeks
(2–3 years), 157–208 weeks (3–5 years), 209–312 weeks
(4–6 years), or>312 weeks (>6 years). The beginning
of a cycle was determined by study intake or the ﬁrst
week of any recurrence following a period of recovery.
The end of a cycle was determined by the week prior
to any recurrence following a period of recovery or
the point at which the participant was lost to follow-
up. A recovery was deﬁned as 8 consecutive weeks
with no or only residual symptoms (PSR f2) on the
major depressive, manic, schizo-aﬀective depressive,
or schizo-aﬀective manic scales of the PSR with
no symptoms on the hypomania, minor depression,
or intermittent depression scales. A recurrence was
deﬁned as any PSR scale >2 lasting 1 or 2 weeks, for
(hypo)manic and depressive symptoms respectively.
Age at cycle onset was included as a continuous
covariate in the assessment of the following risk fac-
tors : gender, feelings of hopelessness, history of sui-
cide attempt, history of multiple suicide attempts,
marital status (married versus others), and substance
abuse. Data on hopelessness were collected only on
intake. With the exception of hopelessness and gender,
the most recent assessment prior to cycle onset was
used for other main eﬀects. The model containing
main eﬀects thus contained the following variables :
age, male gender, hopelessness, married status, prior
suicide attempts, current substance abuse, and
polarity. A diﬀerential eﬀect of these risk factors by
polarity was then assessed. For each assessed polarity
by main eﬀect interaction, the likelihood ratio test
compared the full model with an interaction term to
the reduced model without the interaction term (main
eﬀects only). Each statistical test used a two-tailed a
of 0.05. These mixed-eﬀects grouped-time regression
models were calculated using SuperMix software
(Scientiﬁc Software International, Chicago, IL, USA).
Results
Stability of diagnosis
Diagnostic categories were stable during follow-up
for the majority of participants, although clinically
meaningful rates of conversion from unipolar major
depression to a bipolar disorder were observed during
follow-up. Of the patients who entered the CDS with
unipolar major depression, the prospectively observed
conversion rate to a diagnosis of bipolar II and bipolar
I was 10.6% and 6.9% respectively. Participants were
followed for a mean of 799 (median=988, S.D.=460)
weeks or 15.4 (median=19, S.D.=8.8) years of pro-
spective follow-up. Comparisons of baseline and
demographic variables between diagnostic groups are
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detailed in Table 1. Unipolar patients were signiﬁ-
cantly older than bipolar patients at study intake and
more likely to be married.
Suicide attempts prior to intake into the CDS
Participants with bipolar disorder (38.4%) were
somewhat more likely than those with unipolar dis-
order (28.7%) to have attempted suicide prior to
intake, although bipolar participants were not at sig-
niﬁcantly greater risk for any prior suicide attempt
[hazard ratio (HR) 1.14, 95% conﬁdence interval (CI)
0.95–1.38, p=0.16] or multiple prior suicide attempts
(HR 1.08, 95% CI 0.91–1.39, p=0.38) when age of onset
was controlled for in logistic regression. However,
participants with bipolar disorder were 30% more
likely than those with unipolar disorder to have had
prior severe suicide attempts (HR 1.30, 95% CI 1.09–
1.38, p<0.005), controlling for age of onset in logistic
regression.
Suicide attempts and depressive morbidity after
intake into the CDS
The frequency of suicide outcome measures by
diagnosis during follow-up is detailed in Table 2.
Individuals with bipolar disorder had a greater fre-
quency of suicide attempts during prospective follow-
up than those with unipolar depression (34.0%
v. 27.2%). However, bipolar participants were not
more likely to complete suicide than their unipolar
counterparts (4.4% v. 4.2%). A total of 40 completed
suicides were recorded in this study: 21 among those
with unipolar depression, 19 with bipolar disorder.
Consistent with previously published results (Judd
et al. 2003), signiﬁcant diﬀerences in the percentage of
weeks depressed for each diagnostic category were
observed (Table 2), with bipolar disorder associated
with a lower cumulative depressive burden. Kaplan–
Meier survival curves illustrate suicide attempts and
suicide completions (Fig. 1) over the course of pro-
spective follow-up in the CDS for individuals by pro-
spective diagnosis.
Main eﬀect of risk factors on suicidal behavior :
unipolar versus bipolar
The eﬀect of polarity on suicidal behavior, deﬁned
as suicide attempts or completions, was assessed
in mixed-eﬀects grouped-time survival analysis
(Table 3). Age at cycle onset was included as a con-
tinuous covariate for analysis of main eﬀects. A stat-
istically signiﬁcant linear protective eﬀect of age
was noted (HR 0.95, 95% CI 0.94–0.96, p<0.001).
Independent statistically signiﬁcant main eﬀects were
also seen for hopelessness (HR 3.00, 95% CI 1.97–4.51,
p<0.001) and substance abuse (HR 2.28, 95% CI 1.64–
3.15, p<0.001). The impact of male gender, married
Table 1. Baseline demographic and clinical characteristics of participants by polarity
Unipolar Bipolar Statistics
n 501 435
Female, n (%) 294 (58.7) 250 (57.5)
Age, mean (S.D.) 39.9 (15.0) 36.3 (13.2) t=3.8, df=933, p<0.0001
Educational level, n (%) x2=13.2, df=3, p<0.005
Without diploma 100 (20.1) 53 (12.2)
High school graduate 141 (28.3) 115 (26.4)
Some college 137 (27.5) 147 (33.8)
College graduate 120 (24.1) 120 (27.6)
Marital status, n (%) x2=27.4, df=3, p<0.0001
Married 240 (47.9) 148 (34.0)
Divorced/separated 78 (15.6) 99 (22.8)
Never married 158 (31.5) 178 (40.9)
Widowed 25 (5.0) 10 (2.3)
Prior suicide attempt, n (%) 144 (28.7) 167 (38.4) x2=9.8, df=1, p<0.002
Multiple prior attempts, n (%) 61 (12.2) 79 (18.2) x2=6.6, df=1, p<0.02
Prior severe attempt, n (%) 71 (14.2) 107 (24.6) x2=16.4, df=1, p<0.0001
Information obtained from participants on intake from the Schedule for Aﬀective
Disorders and Schizophrenia (SADS) and Personal History of Depressive Disorders
(PHDD). Diﬀerences in suicide attempts are not signiﬁcant after controlling for age
of onset.
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status and prior suicide attempts did not reach stat-
istical signiﬁcance. Polarity did not independently
predict risk of suicidal behavior.
Diﬀerential eﬀect of risk factors on suicidal
behavior : unipolar versus bipolar
Polarity by main eﬀect interaction terms were indi-
vidually added to the above model to assess for dif-
ferential eﬀects of risk factors on suicidal behavior
by polarity. No statistically signiﬁcant polarity by risk
factor interactions were noted.
Discussion
The increased rate of suicide attempts prior to study
entry in participants with bipolar disorder seems to
largely reﬂect an earlier age of onset, which has been
previously noted with bipolar disorder (McMahon
et al. 1994). Although a trend was noted in our retro-
spective analyses of increased prior suicide attempts
with bipolar disorder compared with unipolar
disorder, the diﬀerences observed were statistically
signiﬁcant, after controlling for age of onset, only for
severe suicide attempts. These ﬁndings diﬀer some-
what with an analysis of the Epidemiologic Catchment
Area database, which revealed an excess of suicide
attempts in individuals with bipolar disorder even
after controlling for age of onset (Chen & Dilsaver,
1996). Although frequency data may have been
suggestive of increased suicidal behaviors during fol-
low-up in participants with bipolar disorder, polarity
did not independently predict suicidal behaviors
when modeled in a mixed-eﬀects grouped-time
survival analysis. Age at cycle onset, hopelessness
at study intake, and active substance abuse did inde-
pendently predict suicidal behavior during mood cy-












































Fig. 1. Survival by aﬀective diagnosis. Kaplan–Meier survival estimates for participants based on prospective diagnosis for time
to : (a) suicide attempt and (b) completed suicide.
Table 2. Frequency of suicidal behavior and proportion of time depressed during follow-up by polarity
Unipolar Bipolar Statistics
Any suicide attempt, n (%) 131 (27.2) 148 (34.0) x2=6.9, df=1, p<0.01
Multiple suicide attempts, n (%) 75 (15.6) 87 (20.0) x2=4.1, df=1, p<0.05
Severe suicide attempt, n (%) 79 (16.4) 97 (22.3) x2=6.5, df=1, p<0.02
Multiple severe suicide attempts, n (%) 35 (7.3) 44 (10.1)
Completed suicide, n (%) 21 (4.2) 19 (4.4)
Weeks depressed, % mean (median, S.D.) (%) 38.6 (27.2, 33.1) 31.7 (22.1, 30.4) Wilcoxon rank sum test, p<0.001
The table outlines the rate of selected suicide outcomes by prospective diagnosis during a median prospective follow-up of
19 years. Severity of suicide attempt was determined by a previously used score ofo4 for intent or lethality on the Schedule
for Aﬀective Disorders and Schizophrenia (SADS).
Suicide risk and risk factors by polarity 767
main eﬀect by polarity interactions and therefore
demonstrated no evidence of diﬀerential eﬀects of risk
factors for suicidal behavior by polarity.
Prior studies have contrasted risk of suicide be-
tween those with bipolar and unipolar disorders with
mixed results. Several studies have assessed suicide
risk factors in unipolar and bipolar disorders (Fawcett
et al. 1990 ; Krupinski et al. 1998 ; Schneider et al. 2001 ;
Angst et al. 2002 ; Oquendo et al. 2007 ; Tondo et al.
2007), and some have conducted separate analyses by
polarity (Black et al. 1988 ; Kallner et al. 2000; Angst
et al. 2005a). An assumption of the former studies is
that risk factors do not vary by diagnosis and the latter
studies do little to validate this assumption. To date,
the assumption that established risk factors do not
vary by polarity has not been empirically tested in a
well-deﬁned prospective cohort. None of these studies
have statistically assessed, using an interaction term,
diﬀerential eﬀects of risk factors by polarity. A com-
munity sample of registered admissions did assess for
diﬀerential eﬀects of risk factors by polarity using an
interaction term, but given the limitations in available
data, was not able to test for any traditionally estab-
lished risk factors apart from age, instead focusing
on variables related to time from hospital admission
(Hoyer et al. 2004). Another study assessed interac-
tions but did not assess diﬀerential aﬀects by diagnosis
or polarity (Young et al. 1994). Our study uniquely
addresses this long-maintained assumption for some
established suicide risk factors and supports the now
empirically validated assessment of risk factors inde-
pendent of polarity in aﬀective disorders.
Of the 4204 cycles assessed, 40 ended in suicide and
384 contained suicide attempts. To ensure adequate
power to assess the diﬀerential eﬀect of risk factors
for suicidal behavior by polarity, we used suicidal
behavior, representing suicide attempts or comple-
tions, as an outcome. The inclusion of suicide attempts
may nonetheless limit the generalizability of our ﬁnd-
ings to the prediction of risk for completed suicide.
Those who complete suicide may represent an over-
lapping but not identical population from those who
attempt suicide (Beautrais, 2001). Furthermore, our
focus on polarity did not allow the assessment of a
diﬀerential eﬀect of risk factors by bipolar subtype.
The lower cumulative depression burden in those
with bipolar disorder reﬂects those with bipolar I,
but not bipolar II, spending less time depressed.
Comparison by bipolar subtype would further allow
assessment of other risk factors, such as mixed states
or cycling. Our analyses controlled for a linear eﬀect of
age on suicide, which may not adequately control for a
non-linear age eﬀect. A signiﬁcant linear eﬀect of age
was nonetheless revealed and analysis of the data did
not suggest a non-linear age eﬀect. The adjustment of
our diagnosis for prospective changes in the psychi-
atric status of participants strengthens the comparison
of these groups by reducing the risk of misclassiﬁca-
tion. Length of follow-up considered, our observed
rate of conversion from unipolar to bipolar disorder
is generally consistent with the previous literature
(Akiskal et al. 1983, 1995 ; Goldberg et al. 2001 ; Angst
et al. 2005b). Screening of vital statistics and obtaining
death certiﬁcates reduces our risk of misclassiﬁcation
for suicide; however, it remains possible that those
who died of unknown causes may in fact have died of
suicide and been misclassiﬁed. The CDS uniquely
provides comprehensive demographic, diagnostic and
phenomenological data for a large clinical sample of
individuals with aﬀective disorders followed for an
extended period of time. Other advantages of this
sample include rigorous clinical evaluations and low
rates of loss to follow-up.
The mixed-eﬀects grouped-time models used in this
analysis pose several advantages for the assessment of
suicide risk factors in a longitudinal study of this
duration. Many studies in psychiatry using survival
analysis have made use of more traditional time-
to-event approaches such as the log-rank test or Cox
proportional hazards models (Leon et al. 1990). These
Table 3. Main eﬀects and main eﬀect by polarity interactions
on suicidal behavior
Main eﬀect HR (95% CI) Likelihood ratio test
Male gender 0.76 (0.55–1.04) x2=0.42, df=1, p=0.52
p=0.87
Hopelessa 3.00 (1.97–4.57) x2=0.01, df=1, p=0.93
p<0.001














Hazard ratios (HRs), 95% conﬁdence intervals (CIs) of
the hazard ratio, and p values for each main eﬀect were
modeled in a mixed-eﬀects, grouped-time survival analysis
to predict suicide attempts or completions. Age at cycle
onset was included as a covariate in the model. Interactions
were compared individually using the likelihood ratio test
for comparing nested models, where the interaction term
was removed for the reduced model.
a Statistically signiﬁcant main eﬀect. There were no
statistically signiﬁcant polarity by risk factor interactions on
risk of suicidal behavior.
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approaches assume independence among obser-
vations and therefore cannot include repeated obser-
vations for each participant. To accommodate changes
in risk factors over time, we changed the unit of
analysis to mood cycle, allowing risk factors to be re-
assessed each cycle. The mixed-eﬀects grouped-time
survival method represents a modern approach to
examining correlated observations, such as multiple
mood cycles, in a single model (Hedeker et al. 2000).
This allows for correlation in within-subject mood
cycles and for the number of mood cycles to vary
widely. All prospectively observed mood cycles were
able to be analyzed together, allowing us to assess
polarity as a predictor of suicidal behavior and a dif-
ferential eﬀect of risk factors by polarity within a mood
cycle. Many of these risk factors vary over time and
our statistical modeling was able to account for this.
The lack of any independent or diﬀerential eﬀects
of polarity on suicide risk poses several clinical and
public health implications. Previous research has
suggested that suicide risk factors may diﬀer between
those with alcoholism and those without (Murphy
et al. 1992). Our data do not support any such diﬀer-
ences by polarity in aﬀective disorders. Although
the presence of an aﬀective disorder shapes suicide
risk assessment, polarity may be of limited relevance
for suicidal risk or the eﬀect of other suicide risk fac-
tors. This information may inform current eﬀorts to
develop standardized tools to augment the clinical
suicide risk assessment. In the light of growing interest
in the use of standardized suicide assessment psy-
chometrics, it will be important to clearly delineate
that suicide risk factors do not vary by diagnosis.
Although the current study suggests no diﬀerences in
risk factors between the bipolar and unipolar dis-
orders, these ﬁndings may not generalize outside of
the aﬀective disorders. Suicide risk remains diﬃcult
to predict (Goldstein et al. 1991) and public health in-
itiatives should continue to target the identiﬁcation
and appropriate treatment of aﬀective disorders as a
general preventative approach (Rihmer, 1996; Mann
et al. 2005).
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